Literature DB >> 27525469

Opioid Overdose: Risk Assessment and Mitigation in Outpatient Treatment.

Lewei Allison Lin1, Avinash Hosanagar, Tae Woo Park, Amy S B Bohnert.   

Abstract

The present clinical case discussion focuses on a patient with comorbid substance use disorder (SUD) and chronic pain, who experienced an overdose of heroin. The case illustrates the complex array of risk factors that contribute to overdose risk, discusses the use of naloxone, and highlights the need for further risk mitigation interventions in patients at risk for overdose.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27525469      PMCID: PMC5083151          DOI: 10.1097/ADM.0000000000000241

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  18 in total

1.  Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial.

Authors:  Jürgen Unützer; Wayne Katon; Christopher M Callahan; John W Williams; Enid Hunkeler; Linda Harpole; Marc Hoffing; Richard D Della Penna; Polly Hitchcock Noël; Elizabeth H B Lin; Patricia A Areán; Mark T Hegel; Lingqi Tang; Thomas R Belin; Sabine Oishi; Christopher Langston
Journal:  JAMA       Date:  2002-12-11       Impact factor: 56.272

2.  Universal precautions in pain medicine: a rational approach to the treatment of chronic pain.

Authors:  Douglas L Gourlay; Howard A Heit; Abdulaziz Almahrezi
Journal:  Pain Med       Date:  2005 Mar-Apr       Impact factor: 3.750

3.  Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.

Authors:  Phillip O Coffin; Sean D Sullivan
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

Review 4.  Police officer, deal-maker, or health care provider? Moving to a patient-centered framework for chronic opioid management.

Authors:  Christina Nicolaidis
Journal:  Pain Med       Date:  2011-05-03       Impact factor: 3.750

5.  A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.

Authors:  Johan Kakko; Leif Grönbladh; Kerstin Dybrandt Svanborg; Joachim von Wachenfeldt; Christian Rück; Bob Rawlings; Lars-Håkan Nilsson; Markus Heilig
Journal:  Am J Psychiatry       Date:  2007-05       Impact factor: 18.112

6.  Opioid prescriptions for chronic pain and overdose: a cohort study.

Authors:  Kate M Dunn; Kathleen W Saunders; Carolyn M Rutter; Caleb J Banta-Green; Joseph O Merrill; Mark D Sullivan; Constance M Weisner; Michael J Silverberg; Cynthia I Campbell; Bruce M Psaty; Michael Von Korff
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

7.  The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.

Authors:  Nancy L Wiedemer; Paul S Harden; Isabelle O Arndt; Rollin M Gallagher
Journal:  Pain Med       Date:  2007 Oct-Nov       Impact factor: 3.750

8.  Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives.

Authors:  Karin E Tobin; Susan G Sherman; Peter Beilenson; Christopher Welsh; Carl A Latkin
Journal:  Int J Drug Policy       Date:  2008-04-22

Review 9.  Chronic back pain with possible prescription opioid misuse.

Authors:  Daniel P Alford
Journal:  JAMA       Date:  2013-03-06       Impact factor: 56.272

10.  Development of a Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Veterans' Health Administration Patients.

Authors:  Barbara Zedler; Lin Xie; Li Wang; Andrew Joyce; Catherine Vick; Janet Brigham; Furaha Kariburyo; Onur Baser; Lenn Murrelle
Journal:  Pain Med       Date:  2015-06-05       Impact factor: 3.750

View more
  1 in total

1.  Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions.

Authors:  Fares Qeadan; Erin Fanning Madden
Journal:  Addiction       Date:  2021-08-16       Impact factor: 7.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.